Company Focus
Moderna
Latest Moderna News
Biotechnology
US mRNA specialist Moderna today announced Health Canada has approved mRESVIA (respiratory syncytial virus mRNA vaccine) for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV) in adults 60 years of age and older. 8 November 2024
Related News
Insights
Company Spotlight
A clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies for the treatment of cancer and infectious
diseases
Latest News & Features of interest to Moderna
Pharmaceutical
US pharma major AbbVie announced financial results for the first quarter of 2024, showing that worldwide net revenues were $12.310 billion, an increase of 0.7% on a reported basis, or 1.6% on an operational basis. 26 April 2024
Biotechnology
Bristol Myers Squibb has agreed terms for a new CAR T cell therapy supply agreement worth up to $380 million in upfront and milestone payments. 26 April 2024
Biotechnology
Swedish Orphan Biovitrum, a rare disease company also known as Sobi, is set to raise around 10 billion Swedish kroner ($920 million) in debt. 26 April 2024
Biotechnology
The European Commission (EC) has approved tislelizumab as a treatment for non-small cell lung cancer (NSCLC) across three indications, including first- and second-line use. 26 April 2024
Biotechnology
UK pharma major GSK has launched a lawsuit against Pfizer and BioNTech. 26 April 2024
Biotechnology
Swedish company Alligator Bioscience saw its shares dip as much as 4.5% to 0.88 kroner in erratic trading this morning , after it announced that Finland’s Orion Corporation has selected the lead bispecific antibodies from the companies’ second development program. 26 April 2024
Biotechnology
British pharma major AstraZeneca has presented new data from the INFORM and COVIDRIVE real-world studies at the annual meeting of the European Society of Clinical Microbiology and Infectious Diseases (ECCMID). 26 April 2024
Biotechnology
US biotech Gilead Sciences has announced its first-quarter 2024 financial results. 26 April 2024
Pharmaceutical
US pharma giant Merck & Co raised and narrowed its forecasts for profit and sales for 2024 in presenting its first-quarter financial results. 25 April 2024
Biotechnology
US biotech Cidara Therapeutics has announced as many as three major news updates in a single day. 25 April 2024
Latest In Brief for Moderna
Biotechnology
GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the US Department of Health and Human Services (HHS). 4 October 2024
Latest Relevant Ones To Watch News
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
5 November 2024
18 October 2024
24 September 2024
23 September 2024
16 September 2024
23 August 2024
Relevant Ones to Watch Companies
Refine Search
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze